Search results for: 'outsourcing services'
- Related search terms
- Services 2.0: The New Business Frontier for Profitability
- outsourcing services market colombia
- Services 2.0 (advanced services)
- services+markets
- outsourcing ofstrive processing expans opportunities
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
08 Jun 2022  |  North America  |  Market Research
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...
$2,450.00
Special Price $1,837.50 save 25 %
-
18 Dec 2023  |  North America  |  Market Research
Global Medical Technology (MedTech) Managed Vendor Services Market, Forecast to 2028
Disruption of Conventional Services Transforms Healthcare Systems and Creates New Growth Opportunities
Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Sep 2012  |  Europe  |  Market Research
Analysis of the European Contract Research Outsourcing Markets
Opportunities in the Rapidly Changing Clinical Drug Development Outsourcing Market Across Europe
The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Market Research
Global Bioanalytical Testing Services, 2021–2027
Acquisition of Disruptive Technologies will be the Key to Driving Growth
As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Jan 2020  |  Global  |  Market Research
Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022
Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth
The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Dec 2022  |  North America  |  Frost Radar
Frost Radar™: Global Medical Imaging Managed Equipment Services Market, 2022
A Benchmarking System to Spark Companies to Action ‒ Innovation That Fuels New Deal Flow and Growth Pipelines
As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %